We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Final Guidance Seeks to Speed Interchangeable Biosimilars to Market
Final Guidance Seeks to Speed Interchangeable Biosimilars to Market
The FDA on Friday released a final interchangeability guidance that regulators hope will help speed cheaper biosimilars to patients who need them desperately.